Evidence map›Paper›PMID 34740555›Full record

ArticleThe Lancet. Digital health2022

Evaluating the reliability of mobility metrics from aggregated mobile phone data as proxies for SARS-CoV-2 transmission in the USA: a population-based study.

Nishant Kishore, Aimee R Taylor, Pierre E Jacob, Navin Vembar, Ted Cohen, Caroline O Buckee, Nicolas A Menzies

Abstract readEvaluation StudyValidation Study
In one paragraph

Article in The Lancet. Digital health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Uncovering heterogeneous intercommunity disease transmission from neutral allele frequency time series.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Comparative evaluation of behavioral epidemic models using COVID-19 data.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Advancing Population Health Through Open Environmental Data Platforms.Current topics in behavioral neurosciences · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nishant KishoreDepartment of Epidemiology, Center for Communicable Disease Dynamics, Harvard T H Chan School of Public Health, Boston, MA, USA.
Aimee R TaylorDepartment of Epidemiology, Center for Communicable Disease Dynamics, Harvard T H Chan School of Public Health, Boston, MA, USA; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Pierre E JacobDepartment of Information Systems, Decision Sciences and Statistics, ESSEC Business School, Cergy, France.
Navin VembarCamber Systems, Washington DC, DC, USA.
Ted CohenDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Caroline O BuckeeDepartment of Epidemiology, Center for Communicable Disease Dynamics, Harvard T H Chan School of Public Health, Boston, MA, USA. Electronic address: cbuckee@hsph.harvard.edu.
Nicolas A MenziesDepartment of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

backgroundIn early 2020, the response to the SARS-CoV-2 pandemic focused on non-pharmaceutical interventions, some of which aimed to reduce transmission by changing mixing patterns between people. Aggregated location data from mobile phones are an important source of real-time information about human mobility on a population level, but the degree to which these mobility metrics capture the relevant contact patterns of individuals at risk of transmitting SARS-CoV-2 is not clear. In this study we describe changes in the relationship between mobile phone data and SARS-CoV-2 transmission in the USA.

methodsIn this population-based study, we collected epidemiological data on COVID-19 cases and deaths, as well as human mobility metrics collated by advertisement technology that was derived from global positioning systems, from 1396 counties across the USA that had at least 100 laboratory-confirmed cases of COVID-19. We grouped these counties into six ordinal categories, defined by the National Center for Health Statistics (NCHS) and graded from urban to rural, and quantified the changes in COVID-19 transmission using estimates of the effective reproduction number (R

findingsWe show that the reproduction number is most strongly associated with mobility proxies for change in the travel into counties (0·757 [95% CI 0·689 to 0·857]), but this relationship primarily holds for counties in the three most urban categories as defined by the NCHS. This relationship weakens considerably after the initial 15 weeks of the epidemic (0·442 [-0·492 to -0·392]), consistent with the emergence of more complex local policies and behaviours, including masking.

interpretationOur study shows that the integration of mobility metrics into retrospective modelling efforts can be useful in identifying links between these metrics and R

fundingThere was no funding source for this study.

Indexed as

Cell PhoneModels, TheoreticalPandemicsTravelBenchmarkingCOVID-19Data CollectionHumansPublic HealthReproducibility of ResultsRetrospective StudiesSARS-CoV-2United StatesUrban Population

Identifiers

PMID34740555
PMCPMC8563007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.